Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

2.

The September 2018 issue of Medical Bulletin.

3.

10-year study shows tomosynthesis improves breast cancer detection

4.

Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

5.

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot